IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis

Kate S. OConnor, Golo Ahlenstiel, Vijay Suppiah, Stephen Schibeci, Adrian Ong, Reynold Leung, David Van Der Poorten, Mark W. Douglas, Martin D. Weltman, Graeme J. Stewart, Christopher Liddle, Jacob George, David R. Booth

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Common IFN lambda 3 (IFNL3) variants have been demonstrated to affect spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. The functional basis of these genetic variants has yet to be determined. Data examining the effect of IFNL3, specifically, in innate immune cells is lacking. Here, we determined the expression of IFNL3 and its receptor IFNLR1 in blood immune cell subsets and in HCV-infected livers. Next we assessed their sensitivity to IFNL3. All participants were genotyped for the IFNL3 SNPs rs8099917 and rs12979860. Importantly, unstimulated blood immune cells express significantly higher levels of IFNL3 than HCV liver biopsies. Plasmacytoid dendritic cells (pDCs) are the predominant producers of IFNLR1, especially in response to IFN-α. PBMCs, monocytes and pDCs all respond to IFNL3 based on MxA up-regulation. No differences in IFNL3 expression levels between rs8099917 or rs12979860 genotypes were detected. This is the first study to show peripheral blood pDCs to be the main producers of IFNL3, especially compared with HCV-infected livers. This makes innate immune cells the key players in determining the functional significance of INFL3 polymorphisms in patients with HCV.

LanguageEnglish
Pages598-605
Number of pages8
JournalInnate Immunity
Volume20
Issue number6
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Hepatitis C
  • IFN
  • IFNL3
  • Innate immunity

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Molecular Biology
  • Cell Biology
  • Infectious Diseases

Cite this

OConnor, Kate S. ; Ahlenstiel, Golo ; Suppiah, Vijay ; Schibeci, Stephen ; Ong, Adrian ; Leung, Reynold ; Van Der Poorten, David ; Douglas, Mark W. ; Weltman, Martin D. ; Stewart, Graeme J. ; Liddle, Christopher ; George, Jacob ; Booth, David R. / IFNL3 mediates interaction between innate immune cells : Implications for hepatitis C virus pathogenesis. In: Innate Immunity. 2014 ; Vol. 20, No. 6. pp. 598-605.
@article{f23682703bb7441b8cb10da6f2216c2a,
title = "IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis",
abstract = "Common IFN lambda 3 (IFNL3) variants have been demonstrated to affect spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. The functional basis of these genetic variants has yet to be determined. Data examining the effect of IFNL3, specifically, in innate immune cells is lacking. Here, we determined the expression of IFNL3 and its receptor IFNLR1 in blood immune cell subsets and in HCV-infected livers. Next we assessed their sensitivity to IFNL3. All participants were genotyped for the IFNL3 SNPs rs8099917 and rs12979860. Importantly, unstimulated blood immune cells express significantly higher levels of IFNL3 than HCV liver biopsies. Plasmacytoid dendritic cells (pDCs) are the predominant producers of IFNLR1, especially in response to IFN-α. PBMCs, monocytes and pDCs all respond to IFNL3 based on MxA up-regulation. No differences in IFNL3 expression levels between rs8099917 or rs12979860 genotypes were detected. This is the first study to show peripheral blood pDCs to be the main producers of IFNL3, especially compared with HCV-infected livers. This makes innate immune cells the key players in determining the functional significance of INFL3 polymorphisms in patients with HCV.",
keywords = "Hepatitis C, IFN, IFNL3, Innate immunity",
author = "OConnor, {Kate S.} and Golo Ahlenstiel and Vijay Suppiah and Stephen Schibeci and Adrian Ong and Reynold Leung and {Van Der Poorten}, David and Douglas, {Mark W.} and Weltman, {Martin D.} and Stewart, {Graeme J.} and Christopher Liddle and Jacob George and Booth, {David R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/1753425913503385",
language = "English",
volume = "20",
pages = "598--605",
journal = "Innate Immunity",
issn = "1753-4259",
number = "6",

}

OConnor, KS, Ahlenstiel, G, Suppiah, V, Schibeci, S, Ong, A, Leung, R, Van Der Poorten, D, Douglas, MW, Weltman, MD, Stewart, GJ, Liddle, C, George, J & Booth, DR 2014, 'IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis', Innate Immunity, vol. 20, no. 6, pp. 598-605. https://doi.org/10.1177/1753425913503385

IFNL3 mediates interaction between innate immune cells : Implications for hepatitis C virus pathogenesis. / OConnor, Kate S.; Ahlenstiel, Golo; Suppiah, Vijay; Schibeci, Stephen; Ong, Adrian; Leung, Reynold; Van Der Poorten, David; Douglas, Mark W.; Weltman, Martin D.; Stewart, Graeme J.; Liddle, Christopher; George, Jacob; Booth, David R.

In: Innate Immunity, Vol. 20, No. 6, 01.01.2014, p. 598-605.

Research output: Contribution to journalArticle

TY - JOUR

T1 - IFNL3 mediates interaction between innate immune cells

T2 - Innate Immunity

AU - OConnor, Kate S.

AU - Ahlenstiel, Golo

AU - Suppiah, Vijay

AU - Schibeci, Stephen

AU - Ong, Adrian

AU - Leung, Reynold

AU - Van Der Poorten, David

AU - Douglas, Mark W.

AU - Weltman, Martin D.

AU - Stewart, Graeme J.

AU - Liddle, Christopher

AU - George, Jacob

AU - Booth, David R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Common IFN lambda 3 (IFNL3) variants have been demonstrated to affect spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. The functional basis of these genetic variants has yet to be determined. Data examining the effect of IFNL3, specifically, in innate immune cells is lacking. Here, we determined the expression of IFNL3 and its receptor IFNLR1 in blood immune cell subsets and in HCV-infected livers. Next we assessed their sensitivity to IFNL3. All participants were genotyped for the IFNL3 SNPs rs8099917 and rs12979860. Importantly, unstimulated blood immune cells express significantly higher levels of IFNL3 than HCV liver biopsies. Plasmacytoid dendritic cells (pDCs) are the predominant producers of IFNLR1, especially in response to IFN-α. PBMCs, monocytes and pDCs all respond to IFNL3 based on MxA up-regulation. No differences in IFNL3 expression levels between rs8099917 or rs12979860 genotypes were detected. This is the first study to show peripheral blood pDCs to be the main producers of IFNL3, especially compared with HCV-infected livers. This makes innate immune cells the key players in determining the functional significance of INFL3 polymorphisms in patients with HCV.

AB - Common IFN lambda 3 (IFNL3) variants have been demonstrated to affect spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. The functional basis of these genetic variants has yet to be determined. Data examining the effect of IFNL3, specifically, in innate immune cells is lacking. Here, we determined the expression of IFNL3 and its receptor IFNLR1 in blood immune cell subsets and in HCV-infected livers. Next we assessed their sensitivity to IFNL3. All participants were genotyped for the IFNL3 SNPs rs8099917 and rs12979860. Importantly, unstimulated blood immune cells express significantly higher levels of IFNL3 than HCV liver biopsies. Plasmacytoid dendritic cells (pDCs) are the predominant producers of IFNLR1, especially in response to IFN-α. PBMCs, monocytes and pDCs all respond to IFNL3 based on MxA up-regulation. No differences in IFNL3 expression levels between rs8099917 or rs12979860 genotypes were detected. This is the first study to show peripheral blood pDCs to be the main producers of IFNL3, especially compared with HCV-infected livers. This makes innate immune cells the key players in determining the functional significance of INFL3 polymorphisms in patients with HCV.

KW - Hepatitis C

KW - IFN

KW - IFNL3

KW - Innate immunity

UR - http://www.scopus.com/inward/record.url?scp=84903785382&partnerID=8YFLogxK

U2 - 10.1177/1753425913503385

DO - 10.1177/1753425913503385

M3 - Article

VL - 20

SP - 598

EP - 605

JO - Innate Immunity

JF - Innate Immunity

SN - 1753-4259

IS - 6

ER -